Search the web
Welcome, Guest
[Sign Out, My Account]

Tuesday, September 1 2015 12:20pm ET - U.S. Markets close in 3 hours and 40 minutes.
Industry Center - Drugs - Generic
Industry Center > Drugs - Generic
More On This Industry
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
Top Industries
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Diversified Utilities
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
·Tobacco Products, Other
Complete Industry List...
Morningstar Inc.
In-depth Company Dossier Reports on over 7,500 publicly traded U.S. companies. Click here for your free report.
Industry Market Summary
Drugs - Generic
Composite Value: 1046.9
Today's Change: -0.08%
S&P 500: -2.01%
chart for
[Drugs - Generic (^YHOh785)]
Drugs - Generic News
CelatorĀ® Pharmaceuticals to Present at the Rodman & Renshaw 17th Annual Global Investment Conference
Tue 8:00 am ET (PR Newswire)
EWING, N.J., Sept. 1, 2015 /PRNewswire/ -- Celator Pharmaceuticals, Inc. (CPXX), a biopharmaceutical company that is transforming the science of combination therapy and developing products to improve patient outcomes in cancer, today announced that Scott Jackson, Chief Executive Officer, will present an overview of the company at the Rodman & Renshaw 17th Annual Global Investment Conference in New York on Wednesday, September 9, 2015, at 3:00 p.m. EDT. A live webcast will be available on the investor section of Celator's website at An archived replay of the webcast will be available on the Company's website for 30 days after the conference. Celator Pharmaceuticals, Inc., with locations in Ewing, N.J., and Vancouver, B.C., is a clinical stage biopharmaceutical company that is transforming the science of combination therapy, and developing products to improve patient outcomes in cancer.
Analysis from CHAMPION PHOENIX Trial Highlight the Efficacy of Cangrelor among Patients undergoing PCI via the Radial Approach - (Business Wire)
Agile Therapeutics Announces Completion of Patient Recruitment in Twirla(R) Phase 3 SECURE Clinical Trial - (GlobeNewswire)
More News on Drugs - Generic: Latest News,
Industry Top Performers
Intraday Price Performance% ChangeMarket Cap
More Top Intraday Price Performers...
Market Capitalization% ChangeMarket Cap
LUPIN LTD. [LUPIN.BO] -3.43% $837.3 B
LUPIN LIMITED [LUPIN.NS] -3.88% $836.4 B
More Top Companies by Market Cap...
More Top Performers: by Valuation, by Growth, by Financial Strength
Industry Calendar
Upcoming Events
Date Co Event
09/02/15 CTLT Catalent Inc Q4 2015 Earnings Release
11/10/15 EVT.DE Evotec AG Q3 2015 Earnings Release
11/12/15 MRK.DE Merck KGaA Q3 2015 Earnings Release
More Upcoming Events...
Recent Events
Date Co Event
08/28/15 MDCO The Medicines Company upgraded by Jefferies
08/26/15 MYL Mylan Inc. coverage initiated by Standpoint Research
08/25/15 LCI Lannett Co Inc Common Stock upside earnings surprise (+5.81%)
More Recent Events...
Locate Industry by Company
Enter Symbol:
Industry Statistics
Market Capitalization:15,696B
Price / Earnings:NM
Price / Book:-4.5
Net Profit Margin (mrq):-4.4%
Price To Free Cash Flow (mrq):-7.3
Return on Equity:0.0%
Total Debt / Equity:41.7
Dividend Yield:0.2%
View Industry Browser
Community Spotlight
Most Active Boards
Board Popularity
Unusually Active Boards
Board Variance

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drugs - Generic Headlines
More Finance RSS Feeds

Copyright © 2015 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2015 Morningstar, Inc. All Rights Reserved. Company information © 2015 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?